Neurological Biomarkers Market Size, Share, Growth Analysis, By Type(Genomic, Proteomic, Metabolomic, Imaging), By Application(Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder), By End User(Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, Research Organizations and Others), By Region - Industry Forecast 2024-2031

Neurological Biomarkers Market size was valued at USD 6.13 Billion in 2022 and is poised to grow from USD 6.96 Billion in 2023 to USD 19.31 Billion by 2031, at a CAGR of 13.6% during the forecast period (2024-2031).

Neurological biomarkers are widely used for diagnosing a range of diseases such as autism, Parkinson’s disease, and depression. These biomarkers include metabolomics and imaging, genomic, and proteomic-based biomarkers. These biomarkers can be classified into metabolomics, imaging, genomics and proteomics. The biomarkers can be used for improving the treatment of neurological diseases, accelerate the development of drugs, allow for earlier diagnosis, and allow non-invasive testing. Moreover, pharmaceutical companies are receiving valuable information via digital biomarkers facilitating their clinical trial decision-making, further contributing to the neurological biomarkers market growth.

In the field of personalized medicine neurological biomarker research for neurodegenerative diseases is one of the fastest advancing fields. This evolution in precision medicine is significantly influencing the biopharmaceutical industry, leading to substantial transformations across various players, from biopharma to diagnostics companies, with roles ranging from commercial operations to research and development.  The market is likely to expand due to organizations offering funding at different levels of research, which is positively impacting the market. For instance, National Institutes of Health (NIH) has increased funding for health disparity research in Alzheimer's and brain aging, thus driving market growth.

US Neurological Biomarkers Market is poised to grow at a sustainable CAGR for the next forecast year.